Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife

<b>Background/Objectives</b>: <i>Toxoplasma gondii</i> is a major cause of zoonotic infections in both humans and animals, resulting in significant mortality in susceptible species, such as New World primates and marsupials. Toxoplasmosis is particularly concerning in zoos and wildlife reserves, where outbreaks threaten conservation efforts for endangered species. In the absence of a commercially available vaccine against toxoplasmosis for humans and captive wild animals, current prevention strategies are limited to restricting the access of cats to enclosures, controlling rodent populations, and maintaining strict food hygiene. Recent research has shown promising results with an intranasal vaccine (VXN-Toxo) composed of maltodextrin nanoparticles conjugated with a purified, inactivated <i>T. gondii</i> parasite. This experimental vaccine does not pose a risk of causing disease and offers advantages such as better stability compared with live pathogen-based vaccines. <b>Methods</b>: This study presents a large-scale evaluation of the effect of VXN-Toxo administered to captive wildlife across 20 zoos in Europe and the Americas between 2017 and 2025. Seven hundred and eighty-four animals, representing over 58 species (including primates, marsupials, rodents, and felids), were vaccinated without any adverse events reported. <b>Results</b>: Retrospective mortality data from 20 participating zoological institutions revealed an overall 96.7% reduction-and, in many cases, a complete elimination-of toxoplasmosis-associated deaths post vaccination. <b>Conclusions</b>: These results demonstrate, for the first time, consistent and broad-spectrum protection against <i>T. gondii</i> of different strains in a wide array of captive wildlife species. This universal vaccine represents a promising tool for toxoplasmosis prevention in zoological collections, with significant implications for animal health and conservation strategies.

Authors

Institutions

Publication Details

Journal
Vaccines
Published
2025-08-27
DOI
https://doi.org/10.3390/vaccines13090910
Citations
2
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
4.10

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife

Lina Marcela Henao Montoya, María del Carmen Carmona-Muciño, Job Benjamin Gérard Stumpel, Daniela Ogonczyk-Makowska et al.
2 citations
Vaccines
Toxoplasma gondii Research Studies
4.10
article

Retrospective Analysis of the Impact of Vaccination with an Inactivated Vaccine on Toxoplasmosis-Associated Mortality in Captive Wildlife

Lina Marcela Henao Montoya, María del Carmen Carmona-Muciño, Job Benjamin Gérard Stumpel, Daniela Ogonczyk-Makowska, Didier Boussarie, Didier Betbeder, Benoît Quintard, Mélanie Berthet, Stamatios Alan Tahas, Angelo Scuotto, Kévin Schlax, Juliana Peña Stadlin, Alexis Maillot, Thomas H. Charpentier, Carlos Madrid, Florine Popelin-Wedlarski, Maria Rosário Fraga Oliveira Martins, Viktória Sós‐Koroknai, Alexandre Azevedo, Maïalen Perot, Marloes van Elderen, Anna Modlinska, Alicia Quiévy
article en
2 citations

Abstract

<b>Background/Objectives</b>: <i>Toxoplasma gondii</i> is a major cause of zoonotic infections in both humans and animals, resulting in significant mortality in susceptible species, such as New World primates and marsupials. Toxoplasmosis is particularly concerning in zoos and wildlife reserves, where outbreaks threaten conservation efforts for endangered species. In the absence of a commercially available vaccine against toxoplasmosis for humans and captive wild animals, current prevention strategies are limited to restricting the access of cats to enclosures, controlling rodent populations, and maintaining strict food hygiene. Recent research has shown promising results with an intranasal vaccine (VXN-Toxo) composed of maltodextrin nanoparticles conjugated with a purified, inactivated <i>T. gondii</i> parasite. This experimental vaccine does not pose a risk of causing disease and offers advantages such as better stability compared with live pathogen-based vaccines. <b>Methods</b>: This study presents a large-scale evaluation of the effect of VXN-Toxo administered to captive wildlife across 20 zoos in Europe and the Americas between 2017 and 2025. Seven hundred and eighty-four animals, representing over 58 species (including primates, marsupials, rodents, and felids), were vaccinated without any adverse events reported. <b>Results</b>: Retrospective mortality data from 20 participating zoological institutions revealed an overall 96.7% reduction-and, in many cases, a complete elimination-of toxoplasmosis-associated deaths post vaccination. <b>Conclusions</b>: These results demonstrate, for the first time, consistent and broad-spectrum protection against <i>T. gondii</i> of different strains in a wide array of captive wildlife species. This universal vaccine represents a promising tool for toxoplasmosis prevention in zoological collections, with significant implications for animal health and conservation strategies.

VaccinesVol. 13(9)
University of Calicut (IN), University of Lagos (NG), University of Pavol Jozef Šafárik (SK), Valeo (France) (FR), Australia Zoo (AU), Gelre Hospitals (NL), Wildlands Network (US), Copenhagen Zoo (DK), CHU Ambroise Paré (BE), The Fourth People's Hospital (CN), Universidad Metropolitana (CO), Centre Hospitalier de Saint-Quentin (FR), Manx National Heritage (IM), Escola Universitária Vasco da Gama (PT), Municipality of Medellín (CO), Académie de Paris (FR), Centre Hospitalier de Mulhouse (FR), Universidade de Sorocaba (BR), Observatoire des Sciences de l’Univers Terre Homme Environnement Temps Astronomie (FR), Clinique Les Fontaines (FR), Skin Research Center (FR), Lagos State Health Service Commission (NG)
Phileo by Lesaffre, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Openalex Percentile: Top 6%
Toxoplasma gondii Research Studies
4.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.